New enzymatic method for measurement of paraldehyde: correlation of effects with serum and CSF levels.
D000429:Alcohol Oxidoreductases; D000927:Anticonvulsants / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008722:Methods; D009243:NAD; D010242:Paraldehyde / Q000032:analysis* / Q000097:blood / Q000134:cerebrospinal fluid / Q000627:therapeutic use
D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D009243:NAD; D000429:Alcohol Oxidoreductases; D010242:Paraldehyde